Purification of GSK-3 by affinity chromatography on immobilized axin

Protein Expression and Purification

Volumn 20, Issue 3, 2000, Pages 394-404

  Primot, Aline ^a   Baratte, Blandine ^a   Gompel, Marie ^a   Borgne, Annie ^a   Liabeuf, Sylvie ^b   Romette, Jean Louis ^b   Jho, Eek Hoon ^c   Costantini, Frank ^c   Meijer, Laurent ^a  

^a STATION BIOLOGIQUE   (France)

^b Centre National de la Recherche Scientifique   (France)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Alzheimer's disease; APC; Armadillo; Axin; Cancer; Diabetes; GSK 3 ; Kinase inhibitors; Protein kinase; Screening; WNT; catenin

Indexed keywords

AFFINITY CHROMATOGRAPHY; ALZHEIMER DISEASE; AXIN; BIOCHEMICAL PATHWAY; BIOLOGICAL FUNCTIONS; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME PURIFICATION; ESCHERICHIA COLI; GLYCOGEN SYNTHASE KINASE 3; IMMOBILIZED PROTEIN; PHOSPHOTRANSFERASE; PROTEIN IMMOBILIZATION; PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION;

ARMADILLO; ECHINOIDEA; ESCHERICHIA COLI; SUIDAE;

EID: 0033662579     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.2000.1321     Document Type: Article

References (51)

1. Glycogen synthase kinase 3 from rabbit skeletal muscle
2. Purification of glycogen synthase kinase 3 from rabbit skeletal muscle. Copurification with the activating factor (FA) of the (Mg-ATP) dependent protein phosphatase
3. Molecular cloning and expression of glycogen synthase kinase-3/factor A
4. Isolation and chromosomal mapping of human glycogen synthase kinase-3α and -3β encoding genes
5. Chromosomal mapping and mutational analysis of the coding region of the glycogen synthase kinase-3α and -3β isoforms in patients with NIDDM
6. Expression analysis of glycogen synthase kinase-3 in human tissues
7. β-catenin: A key mediator of Wnt signaling
8. Wnt signalling in mammalian development and cancer
9. Biochemical interactions in the wnt pathway
10. Glycogen synthase kinase 3 and dorso-ventral pattering in Xenopus embryos
11. The mouse Fused locus encodes axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation
12. The axis-reducing activity, stability, and subcellular distribution of β-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3
13. GSK-3β/Shaggy mediates patterning along the animal-vegetal axis of the sea urchin embryo
14. The role of glycogen synthase kinase 3β in insulin-stimulated glucose metabolism
15. The Croonian Lecture 1998. Identification of a protein kinase cascade of major importance in insulin signal transduction
16. Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
17. Downregulation of β-catenin by human axin and its association with the APC tumor suppressor, β-catenin and GSK3β
18. Activation of β-catenin-TCF signaling in colon cancer by mutations in β-catenin or APC
19. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas
20. APC: The plot thickens
21. β-catenin signaling and cancer
22. Signaling through β-catenin and Lef/Tcf
23. Stabilization of β-catenin by genetic defects in melamona cell lines
24. Inhibition of GSK-3β leading to the loss of phosphorylated MAP-1B is an early event in axonal remodelling induced by WNT-7a or lithium
25. HIV-1 Tat-mediated activation of glycogen synthase kinase-3β contributes to tat-mediated neurotoxicity
26. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration
27. Sequential phosphorylation of tau-protein by GSK-3β and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT-100 and requires a paired helical filament-like conformation
28. Phosphorylation of tau protein by recombinant GSK-3: Pronounced phosphorylation at select Ser/Thr-Pro motifs but no phosphorylation at Ser262 in the repeat domain
29. Lithium reduces Tau phosphorylation by inhibition of glycogen synthase kinase-3
30. Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons
31. Distribution of active glycogen synthase kinase 3β (GSK-3β) in brains staged for Alzheimer disease neurofibrillary changes
32. Physiology and pathology of tau protein kinases in relation to Alzheimer's disease
33. Tau in Alzheimer's disease
34. The effects of a lethal mutation responsible for duplications and twinning in mouse embryos
35. Down-regulation of β-catenin by human axin and its association with the APC tumor suppressor, β-catenin, and GSK-3β
36. Domains of axin involved in protein-protein interactions, Wnt pathway inhibition, and intracellular localization
37. Axis determination in Xenopus involves biochemical interactions of axin, glycogen synthase kinase 3 and β-catenin
38. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin
39. Bridging of β-catenin and glycogen synthase kinase-3β by axin and inhibition of β-catenin-mediated transcription
40. Functional domains of axin. Importance of the C terminus as an oligomerization domain
41. Functional interaction of an axin homolog conductin, with β-catenin, APC, and GSK3β
42. Axin and Frat1 interact with Dv1 and GSK, bridging Dv1 to GSK in Wnt-mediated regulation of LEF-1
43. Axin directly interacts with plakoglobin and regulates its stability
44. Identification of a domain of axin that binds to the serine/threonine protein phosphatase 2A and a self-binding domain
45. GSK-3β-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by β-catenin and protein phosphatase 2A complexed with axin
46. Axin forms a complex with MEKK1 and activates c-Jun NH2-terminal kinase/stress-activated protein kinase through domains distinct from Wnt signaling
47. Baculovirus-mediated expression and characterisation of rat glycogen synthase kinase-3β, the mammalian homologue of the Drosophila melanogaster zeste-white homeotic gene product
48. A molecular mechanism for the effect of lithium on development
49. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signaling in intact cells
50. Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation
51. Peptide substrates suitable for assaying glycogen synthase kinase-3 in crude cell extracts